GGrantIndex
← Search

PHASE 1/2B TESTING OF THE SM-TSP-2 SCHISTOSOMIASIS VACCINE IN UGANDA

$4,855,944FY2018Defense Health AgencyDOD

George Washington University (The)

Investigators

View source on USAspending →
PHASE 1/2B TESTING OF THE SM-TSP-2 SCHISTOSOMIASIS VACCINE IN UGANDA · GrantIndex